Abnormal Levels of Inflammatory and Oxidative Stress Markers in Patients with Arterial Hypertension and Diabetes Mellitus
References
- 1. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105(9): 1135-43.
- 2. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003; 169(2): 203-14.
- 3. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BM J. 2000;321 (7255): 199-204.
- 4. Castoldi G, Galimbertim S, Riva C, Papagna R, Querci F, Casati M, et al. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes. Clin Sci (Lond). 2007; 113(2): 103-8.
- 5. Elkind M. Inflammatory mechanisms of stroke. Stroke. 2010; 41 (10 Suppl):S3-S8.
- 6. Libby P, Ridker P. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004; 116(6 Suppl 1):9S-16S.
- 7. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340(2): 115-26.
- 8. Di Napoli M, Elkind M, Godoy D, Singh P, Papa F, Popa-Wagner A. Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther. 2011 ;9( 12): 1565-84.
- 9. Pasupathi P, Farook J, Chinnaswamy P. Oxidant-antioxidant status, high sensitive C-reactive protein and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Int J Biol Med Res. 2010; 1 (3) :04-8.
- 10. Likidlilid A, Patchanans N, Peerapatdit T. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai. 2010;93(6):682-93.
- 11. Lindsberg P, Grau A. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34(10):2518-32.
- 12. Saito M, Ishimittsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional risk factors. Atherosclerosis. 2003; 167( 1 ):73-9.
- 13. Anand A, Manikandan R, Begum T, Kumar K, Akilandeswari G, Jerline M, et al. Hypertension, diabetes, metabolic syndrome, inflammation and the risk of stroke. Int J Biol Med Res. 2011 ;2( 1 ):429-32.
- 14. Savoia C, Schiffrin E. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond). 2007; 112(7):375-84.
- 15. Di Napoli M, Papa F. Inflammation, hemostatic factors and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke. 2002; 33:1763-71.
- 16. Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008;79(8 Suppl): 1544-51.
- 17. Biswas UK, Kumar A. Study on lipid profile, oxidation stress and carbonic anhydrase activity in patients with essential hypertension. J Clin Diag Res. 2010;4:3414-20.
- 18. Kusano C, Ferrari B. Total antioxidant capacity: a biomarker in biomedical and nutritional studies. J Cell Mol Biol. 2008;7(1): 1-15.
- 19. Mahboob M, Rahman M, Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J. 2005;46(7):322-4.
DOI: https://doi.org/10.1515/jbcr-2015-0107 | Journal eISSN: 1313-9053
Language: English
Page range: 89 - 93
Submitted on: Nov 17, 2013
Accepted on: Dec 27, 2013
Published on: Nov 30, 2016
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2016 Maya P. Danovska, Margarita L. Alexandrova, Irena I. Gencheva, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.